Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine
This article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genom...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-01-01
|
Series: | Healthcare |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9032/4/1/6 |
id |
doaj-69c40ff8755f4b29b34c48851c14fef0 |
---|---|
record_format |
Article |
spelling |
doaj-69c40ff8755f4b29b34c48851c14fef02020-11-25T00:46:41ZengMDPI AGHealthcare2227-90322016-01-0141610.3390/healthcare4010006healthcare4010006Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic MedicineDeborah Cragun0Courtney Lewis1Lucia Camperlengo2Tuya Pal3College of Public Health, Department of Global Health, University of South Florida, Tampa, FL 33620, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAMoffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612, USAThis article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genomic medicine. First, we evaluate genetic service delivery through triangulating patient and provider survey results which reveal variability among providers in hereditary cancer knowledge and genetic service provision. Second, we describe efforts we have made to assure competency among healthcare providers and to inform, educate and empower patients with regard to the rapidly evolving field of genomics and hereditary cancer. Lastly, key policy-issues raised by our experiences are discussed in the context of how they may help us to more effectively translate future genomic technologies into practice in order to attain population health benefits from genetic and genomic medicine.http://www.mdpi.com/2227-9032/4/1/6genetic testinghereditary breast and ovarian cancer syndromegenomicspublic health |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Deborah Cragun Courtney Lewis Lucia Camperlengo Tuya Pal |
spellingShingle |
Deborah Cragun Courtney Lewis Lucia Camperlengo Tuya Pal Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine Healthcare genetic testing hereditary breast and ovarian cancer syndrome genomics public health |
author_facet |
Deborah Cragun Courtney Lewis Lucia Camperlengo Tuya Pal |
author_sort |
Deborah Cragun |
title |
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine |
title_short |
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine |
title_full |
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine |
title_fullStr |
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine |
title_full_unstemmed |
Hereditary Cancer: Example of a Public Health Approach to Ensure Population Health Benefits of Genetic Medicine |
title_sort |
hereditary cancer: example of a public health approach to ensure population health benefits of genetic medicine |
publisher |
MDPI AG |
series |
Healthcare |
issn |
2227-9032 |
publishDate |
2016-01-01 |
description |
This article introduces the identification, prevention, and treatment of hereditary cancer as an important public health concern. Hereditary cancer research and educational outreach activities are used to illustrate how public health functions can help to achieve health benefits of genetic and genomic medicine. First, we evaluate genetic service delivery through triangulating patient and provider survey results which reveal variability among providers in hereditary cancer knowledge and genetic service provision. Second, we describe efforts we have made to assure competency among healthcare providers and to inform, educate and empower patients with regard to the rapidly evolving field of genomics and hereditary cancer. Lastly, key policy-issues raised by our experiences are discussed in the context of how they may help us to more effectively translate future genomic technologies into practice in order to attain population health benefits from genetic and genomic medicine. |
topic |
genetic testing hereditary breast and ovarian cancer syndrome genomics public health |
url |
http://www.mdpi.com/2227-9032/4/1/6 |
work_keys_str_mv |
AT deborahcragun hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine AT courtneylewis hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine AT luciacamperlengo hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine AT tuyapal hereditarycancerexampleofapublichealthapproachtoensurepopulationhealthbenefitsofgeneticmedicine |
_version_ |
1725263784019230720 |